Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Interest Expenses (2021 - 2026)

Lucid Diagnostics filings provide 4 years of Interest Expenses readings, the most recent being $6000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 14.29% to $6000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $23000.0, a 11.54% decrease, with the full-year FY2025 number at $22000.0, down 15.38% from a year prior.
  • Interest Expenses hit $6000.0 in Q4 2025 for Lucid Diagnostics, up from $2000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $447000.0 in Q3 2021 to a low of $1000.0 in Q3 2024.
  • Median Interest Expenses over the past 4 years was $11000.0 (2023), compared with a mean of $74933.3.
  • Biggest five-year swings in Interest Expenses: tumbled 99.33% in 2024 and later skyrocketed 100.0% in 2025.
  • Lucid Diagnostics' Interest Expenses stood at $65000.0 in 2021, then plummeted by 83.08% to $11000.0 in 2023, then tumbled by 36.36% to $7000.0 in 2024, then dropped by 14.29% to $6000.0 in 2025.
  • The last three reported values for Interest Expenses were $6000.0 (Q4 2025), $2000.0 (Q3 2025), and $6000.0 (Q2 2025) per Business Quant data.